Profile data is unavailable for this security.
About the company
Jiangsu gdk Biotechnology Co Ltd is a biopharmaceutical company engaged in the research, development, production, and sales of human vaccines. The Company’s main product is a tetravalent influenza virus split vaccine, which is mainly used to prevent influenza caused by two influenza A virus strains and two influenza B virus strains. The Company's research products also include a variety of human vaccines for the prevention of epidemic colds, rabies, chickenpox, shingles, and pneumonia. The Company distributes its service within the domestic market.
- Revenue in CNY (TTM)10.74m
- Net income in CNY-146.94m
- Incorporated2008
- Employees451.00
- LocationJiangsu GDK Biotechnology Co LtdNo. 12 Yujin RoadTAIZHOU 225300ChinaCHN
- Phone+86 52 386205860
- Fax+86 52 386200152
- Websitehttp://www.gdkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shaanxi Kanghui Pharmaceutical Co Ltd | 669.33m | -47.46m | 1.26bn | 952.00 | -- | 1.34 | -- | 1.88 | -0.4752 | -0.4752 | 6.70 | 9.42 | 0.3167 | 1.94 | 3.35 | 703,079.60 | -3.63 | -0.1562 | -5.54 | -0.1991 | 26.27 | 40.00 | -11.48 | -0.4907 | 0.8792 | -0.7684 | 0.4201 | 95.15 | 36.92 | 12.37 | 58.52 | -- | 66.95 | -- |
Qinghai Spring Medicinl Rsrcs Tech CoLTD | 244.84m | -277.14m | 1.53bn | 173.00 | -- | 1.28 | -- | 6.23 | -0.4721 | -0.4721 | 0.417 | 2.03 | 0.1757 | 0.4712 | 4.67 | 1,415,236.00 | -19.74 | -11.25 | -20.38 | -11.55 | 48.62 | 23.44 | -112.37 | -129.81 | 8.87 | -0.8971 | 0.0135 | -- | 33.52 | -8.48 | 6.85 | -- | -20.83 | -- |
Jiangsu gdk Biotechnology Co Ltd | 10.74m | -146.94m | 1.53bn | 451.00 | -- | 1.15 | -- | 142.28 | -1.19 | -1.19 | 0.0871 | 10.80 | 0.0064 | 0.1697 | 0.0778 | 23,806.61 | -8.73 | 3.30 | -10.20 | 4.84 | -1.88 | 75.56 | -1,368.55 | 12.58 | 3.10 | -- | 0.0412 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
Shanghai Shen Lian Biomedical Corp | 304.79m | -12.92m | 1.91bn | 380.00 | -- | 1.32 | -- | 6.25 | -0.0315 | -0.0315 | 0.7422 | 3.51 | 0.196 | 0.9229 | 1.15 | 802,082.80 | -1.06 | 5.39 | -1.12 | 5.84 | 64.36 | 77.45 | -5.42 | 25.48 | 5.16 | -- | 0.0015 | 38.49 | -8.25 | 1.85 | -48.41 | -18.49 | 10.47 | -- |
Shanghai Serum Bio-Technology Co Ltd | 194.44m | 44.17m | 2.06bn | 321.00 | 46.57 | 1.88 | -- | 10.58 | 0.4082 | 0.4082 | 1.80 | 10.13 | 0.1738 | 1.03 | 3.49 | 605,741.10 | 3.95 | 10.43 | 4.02 | 10.84 | 75.64 | 80.54 | 22.72 | 32.57 | 49.77 | -- | 0.0114 | 64.93 | 9.14 | 5.67 | -39.54 | -1.62 | 13.07 | -- |
Data as of Oct 11 2024. Currency figures normalised to Jiangsu GDK Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 412.27k | 0.96% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 364.50k | 0.85% |
Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 132.70k | 0.31% |
Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 50.16k | 0.12% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 42.83k | 0.10% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 34.02k | 0.08% |
Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 20.20k | 0.05% |
Oriental Alpha Fund Management Co. Ltd.as of 31 Dec 2023 | 9.29k | 0.02% |
HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 8.50k | 0.02% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 4.98k | 0.01% |
More ▼
Data from 31 Dec 2023 - 06 Aug 2024Source: FactSet Research Systems Inc.